Skip to main content
Erschienen in: Clinical Autonomic Research 2/2018

10.10.2017 | Research Article

Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities

verfasst von: Octávio Barbosa Neto, Gustavo Ribeiro da Mota, Carla Cristina De Sordi, Elisabete Aparecida M. R. Resende, Luiz Antônio P. R. Resende, Marco Antônio Vieira da Silva, Moacir Marocolo, Rafael Silva Côrtes, Lucas Felipe de Oliveira, Valdo José Dias da Silva

Erschienen in: Clinical Autonomic Research | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aims of this study were to examine the hypothesis that users of anabolic androgenic steroids (AAS) would have cardiac autonomic disorders and that there is a correlation between sympathetic modulation, high blood pressure (BP) and alterations to cardiac dimensions.

Methods

Forty-five male subjects were enrolled in the study. They were categorized into three groups comprising bodybuilders actively using AAS (AAS users; n = 15), bodybuilders who had never used AAS (nonusers; n = 15) and age-paired healthy sedentary controls (n = 15). Hemodynamic parameters, linear and nonlinear analyses of heart rate variability and electrocardiography and echocardiography analyses were performed at rest.

Results

Bodybuilders in the AAS group had a higher mean BP than those in the ASS nonuser group (p < 0.05) and the sedentary controls (p < 0.001). Cardiac sympathetic modulation was higher in AAS users than in AAS nonusers (p < 0.05) and the sedentary controls (p < 0.001), and parasympathetic modulation was lower in AAS users than in nonusers and the sedentary controls (p < 0.05). Shannon entropy was lower in AAS users than in the sedentary (p < 0.05) controls, and the corrected QT interval and QT dispersion were higher in AAS users than in the sedentary controls (p < 0.05). The interventricular septal thickness, left ventricle posterior wall thickness and relative diastolic wall thickness were higher in AAS users than in AAS nonusers and the sedentary controls (p < 0.001). AAS users showed a positive correlation between increased sympathetic modulation and high BP (r = 0.48, p < 0.005), as well as sympathetic modulation and cardiac hypertrophy (r = 0.66, p < 0.001).

Conclusion

There was a marked cardiac autonomic alteration in AAS users, with a shift toward sympathetic modulation predominance and vagal attenuation. The high BP observed in our group of bodybuilders using AAS was associated with increased sympathetic modulation, and this increased sympathetic modulation was associated with structural alterations in the heart. This association may constitute an important mechanism linking AAS abuse to increased cardiovascular risk.
Literatur
1.
Zurück zum Zitat Martinez-Quintana E, Saiz-Udaeta B, Marrero-Negrin N, Lopez-Merida X, Rodriguez-Gonzalez F, Nieto-Lago V (2013) Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects. Int J Endocrinol Metab 11:e8755PubMedPubMedCentral Martinez-Quintana E, Saiz-Udaeta B, Marrero-Negrin N, Lopez-Merida X, Rodriguez-Gonzalez F, Nieto-Lago V (2013) Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects. Int J Endocrinol Metab 11:e8755PubMedPubMedCentral
2.
Zurück zum Zitat Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ (1998) Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98:256–261CrossRefPubMed Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ (1998) Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98:256–261CrossRefPubMed
3.
4.
Zurück zum Zitat Baume N, Schumacher YO, Sottas PE, Bagutti C, Cauderay M, Mangin P et al (2006) Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects. Eur J Appl Physiol 98:329–340CrossRefPubMed Baume N, Schumacher YO, Sottas PE, Bagutti C, Cauderay M, Mangin P et al (2006) Effect of multiple oral doses of androgenic anabolic steroids on endurance performance and serum indices of physical stress in healthy male subjects. Eur J Appl Physiol 98:329–340CrossRefPubMed
5.
Zurück zum Zitat Alves MJ, Dos Santos MR, Dias RG, Akiho CA, Laterza MC, Rondon UM et al (2010) Abnormal neurovascular control in anabolic androgenic steroids users. Med Sci Sports Exerc 42:865–871CrossRefPubMed Alves MJ, Dos Santos MR, Dias RG, Akiho CA, Laterza MC, Rondon UM et al (2010) Abnormal neurovascular control in anabolic androgenic steroids users. Med Sci Sports Exerc 42:865–871CrossRefPubMed
6.
Zurück zum Zitat Achar S, Rostamian A, Narayan SM (2010) Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. Am J Cardiol 106:893–901CrossRefPubMedPubMedCentral Achar S, Rostamian A, Narayan SM (2010) Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. Am J Cardiol 106:893–901CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Parssinen M, Seppala T (2002) Steroid use and long-term health risks in former athletes. Sports Med 32:83–94CrossRefPubMed Parssinen M, Seppala T (2002) Steroid use and long-term health risks in former athletes. Sports Med 32:83–94CrossRefPubMed
8.
Zurück zum Zitat McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ (1998) Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 62:164CrossRef McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ (1998) Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 62:164CrossRef
9.
Zurück zum Zitat Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065CrossRef
10.
Zurück zum Zitat Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovascular neural regulation explored in the frequency domain. Circulation 84:482–492CrossRefPubMed Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovascular neural regulation explored in the frequency domain. Circulation 84:482–492CrossRefPubMed
11.
Zurück zum Zitat Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A (1994) Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 90:1826–1831CrossRefPubMed Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A (1994) Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 90:1826–1831CrossRefPubMed
12.
Zurück zum Zitat Mäkikallio TH, Seppanen T, Niemela M, Airaksinen KE, Tulppo M, Huikuri HV (1996) Abnormalities in beat to beat complexity of heart rate dynamics in patients with a previous myocardial infarction. J Am Coll Cardiol 28:1005–1011CrossRefPubMed Mäkikallio TH, Seppanen T, Niemela M, Airaksinen KE, Tulppo M, Huikuri HV (1996) Abnormalities in beat to beat complexity of heart rate dynamics in patients with a previous myocardial infarction. J Am Coll Cardiol 28:1005–1011CrossRefPubMed
13.
Zurück zum Zitat Krstacic G, Krstacic A, Smalcelj A, Milicic D, Jembrek-Gostovic M (2007) The “Chaos Theory” and nonlinear dynamics in heart rate variability analysis: does it work in short-time series in patients with coronary heart disease? Ann Noninvasive Electrocardiol 12:130–136CrossRefPubMed Krstacic G, Krstacic A, Smalcelj A, Milicic D, Jembrek-Gostovic M (2007) The “Chaos Theory” and nonlinear dynamics in heart rate variability analysis: does it work in short-time series in patients with coronary heart disease? Ann Noninvasive Electrocardiol 12:130–136CrossRefPubMed
14.
Zurück zum Zitat Guzzetti S, Borroni E, Garbelli PE, Ceriani E, Della BP, Montano N et al (2005) Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation 112:465–470CrossRefPubMed Guzzetti S, Borroni E, Garbelli PE, Ceriani E, Della BP, Montano N et al (2005) Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation 112:465–470CrossRefPubMed
15.
Zurück zum Zitat Porta A, Guzzetti S, Montano N, Furlan R, Pagani M, Malliani A et al (2001) Entropy, entropy rate and pattern classification as tools to typify complexity in short heart period variability series. IEEE Trans Biomed Eng 48:1282–1291CrossRefPubMed Porta A, Guzzetti S, Montano N, Furlan R, Pagani M, Malliani A et al (2001) Entropy, entropy rate and pattern classification as tools to typify complexity in short heart period variability series. IEEE Trans Biomed Eng 48:1282–1291CrossRefPubMed
16.
Zurück zum Zitat Pantoni CB, Di Thommazo L, Mendes RG, Catai AM, Luzzi S, Amaral NO et al (2011) Effects of different levels of positive airway pressure on breathing pattern and heart rate variability after coronary artery bypass grafting surgery. Braz J Med Biol Res 44:38–45CrossRefPubMed Pantoni CB, Di Thommazo L, Mendes RG, Catai AM, Luzzi S, Amaral NO et al (2011) Effects of different levels of positive airway pressure on breathing pattern and heart rate variability after coronary artery bypass grafting surgery. Braz J Med Biol Res 44:38–45CrossRefPubMed
17.
Zurück zum Zitat Perseguini NM, Takahashi AC, Rebelatto JR, Silva E, Borghi-Silva A, Porta A et al (2011) Spectral and symbolic analysis of the effect of gender and postural change on cardiac autonomic modulation in healthy elderly subjects. Braz J Med Biol Res 44:29–37CrossRefPubMed Perseguini NM, Takahashi AC, Rebelatto JR, Silva E, Borghi-Silva A, Porta A et al (2011) Spectral and symbolic analysis of the effect of gender and postural change on cardiac autonomic modulation in healthy elderly subjects. Braz J Med Biol Res 44:29–37CrossRefPubMed
18.
Zurück zum Zitat Pincus S (2000) Aproximate entropy in cardiology. Herzschr Elektrophys 11:139–150CrossRef Pincus S (2000) Aproximate entropy in cardiology. Herzschr Elektrophys 11:139–150CrossRef
19.
Zurück zum Zitat Kanayama G, Hudson JI, Pope HG (2009) Demographic and psychiatric features of men with anabolic-androgenic steroid dependence: a comparative study. Drug Alcohol Depend 102:130–137CrossRefPubMedPubMedCentral Kanayama G, Hudson JI, Pope HG (2009) Demographic and psychiatric features of men with anabolic-androgenic steroid dependence: a comparative study. Drug Alcohol Depend 102:130–137CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kunz VC, Borges EN, Coelho RC, Gubolino LA, Martins LEB, Silva E (2012) Linear and nonlinear analysis of heart rate variability in healthy subjects and after acute myocardial infarction in patients. Braz J Med Biol Res 45:450–458CrossRefPubMedPubMedCentral Kunz VC, Borges EN, Coelho RC, Gubolino LA, Martins LEB, Silva E (2012) Linear and nonlinear analysis of heart rate variability in healthy subjects and after acute myocardial infarction in patients. Braz J Med Biol Res 45:450–458CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Billman GE (2013) The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 4:1–4 Billman GE (2013) The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 4:1–4
22.
Zurück zum Zitat Pereira-Junior PP, Chaves EA, Costa-E-Sousa RH, Masuda MO, de Carvalho AC, Nascimento JH (2006) Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur J Appl Physiol 96:487–494CrossRefPubMed Pereira-Junior PP, Chaves EA, Costa-E-Sousa RH, Masuda MO, de Carvalho AC, Nascimento JH (2006) Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur J Appl Physiol 96:487–494CrossRefPubMed
23.
Zurück zum Zitat Maior AS, Carvalho AR, Marques-Neto SR, Menezes P, Soares PP, Nascimento JHM (2012) Cardiac autonomic dysfunction in anabolic steroid users. Scand J Med Sci Sports 23:548–555PubMed Maior AS, Carvalho AR, Marques-Neto SR, Menezes P, Soares PP, Nascimento JHM (2012) Cardiac autonomic dysfunction in anabolic steroid users. Scand J Med Sci Sports 23:548–555PubMed
24.
Zurück zum Zitat Christou GA, Christou KA, Nikas DN, Goudevenos JA (2016) Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: a case report and critical review of the literature. Eur J Prev Cardiol 23:1785–1796CrossRefPubMed Christou GA, Christou KA, Nikas DN, Goudevenos JA (2016) Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: a case report and critical review of the literature. Eur J Prev Cardiol 23:1785–1796CrossRefPubMed
25.
Zurück zum Zitat Sader MA, Griffiths KA, McCredie RJ, Handelsman DJ, Celermajer DS (2001) Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37:224–230CrossRefPubMed Sader MA, Griffiths KA, McCredie RJ, Handelsman DJ, Celermajer DS (2001) Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol 37:224–230CrossRefPubMed
26.
Zurück zum Zitat Pouliot WA, Handa RJ, Beck SG (1996) Androgen modulates N-methylo-aspartate-mediated depolarization in CAI hippocampal pyramidal cells. Synapse 23:10–19CrossRefPubMed Pouliot WA, Handa RJ, Beck SG (1996) Androgen modulates N-methylo-aspartate-mediated depolarization in CAI hippocampal pyramidal cells. Synapse 23:10–19CrossRefPubMed
27.
Zurück zum Zitat Green DJ, Cable NT, Rankin JM, Fox C, Taylor RR (1993) Anabolic steroids and vascular responses. Lancet 342:863CrossRefPubMed Green DJ, Cable NT, Rankin JM, Fox C, Taylor RR (1993) Anabolic steroids and vascular responses. Lancet 342:863CrossRefPubMed
28.
Zurück zum Zitat Karhunen MK, Ramo MP, Kettunen R (1988) Anabolic steroids alter the haemodynamic effects of endurance training and deconditioning in rats. Acta Physiol Scand 133:297–306CrossRefPubMed Karhunen MK, Ramo MP, Kettunen R (1988) Anabolic steroids alter the haemodynamic effects of endurance training and deconditioning in rats. Acta Physiol Scand 133:297–306CrossRefPubMed
29.
Zurück zum Zitat De Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E (1991) Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med 12:408–412CrossRefPubMed De Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E (1991) Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med 12:408–412CrossRefPubMed
30.
Zurück zum Zitat Hartgens F, Cheriex EC, Kuipers H (2003) Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. Int J Sports Med 24:344–351CrossRefPubMed Hartgens F, Cheriex EC, Kuipers H (2003) Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. Int J Sports Med 24:344–351CrossRefPubMed
32.
Zurück zum Zitat Hart G (2003) Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes? Exp Physiol 88:639–644CrossRefPubMed Hart G (2003) Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes? Exp Physiol 88:639–644CrossRefPubMed
34.
Zurück zum Zitat Grassi G, Giannattasio C, Cléroux J, Cuspidi C, Sampieri L, Bolla GB et al (1988) Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension. Hypertension 12:227–237CrossRefPubMed Grassi G, Giannattasio C, Cléroux J, Cuspidi C, Sampieri L, Bolla GB et al (1988) Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension. Hypertension 12:227–237CrossRefPubMed
35.
Zurück zum Zitat Frati P, Busardò FP, Cipolloni L, Dominicis E, Fineschi V (2015) Anabolic androgenic steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol 13:146–159CrossRefPubMedPubMedCentral Frati P, Busardò FP, Cipolloni L, Dominicis E, Fineschi V (2015) Anabolic androgenic steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol 13:146–159CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Liu XK, Katchman A, Whitfield BH, Wan G, Janowski EM, Woosley RL et al (2003) In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res 57:28–36CrossRefPubMed Liu XK, Katchman A, Whitfield BH, Wan G, Janowski EM, Woosley RL et al (2003) In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res 57:28–36CrossRefPubMed
37.
Zurück zum Zitat Rocha FL, Carmo EC, Roque FR, Hashimoto NY, Rossoni LV, Frimm C et al (2007) Anabolic steroids induce cardiac renin angiotensin system and impair the beneficial effects of aerobic training in rats. Am J Physiol Heart Circ Physiol 293:H3575–H3583CrossRefPubMed Rocha FL, Carmo EC, Roque FR, Hashimoto NY, Rossoni LV, Frimm C et al (2007) Anabolic steroids induce cardiac renin angiotensin system and impair the beneficial effects of aerobic training in rats. Am J Physiol Heart Circ Physiol 293:H3575–H3583CrossRefPubMed
38.
Zurück zum Zitat Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S (1994) Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 90:928–936CrossRefPubMed Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S (1994) Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 90:928–936CrossRefPubMed
39.
Zurück zum Zitat Burl VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M et al (1995) Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 25:305–313CrossRef Burl VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M et al (1995) Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 25:305–313CrossRef
40.
Zurück zum Zitat Palatini P, Giada F, Garavelli G, Sinisi F, Mario L, Michieletto M et al (1996) Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36:132–140CrossRef Palatini P, Giada F, Garavelli G, Sinisi F, Mario L, Michieletto M et al (1996) Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 36:132–140CrossRef
41.
Zurück zum Zitat Roşca AE, Stoian I, Badiu C, Gaman L, Popescu O, Iosif L et al (2016) Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats. Braz J Med Biol Res 49:e5116PubMedPubMedCentral Roşca AE, Stoian I, Badiu C, Gaman L, Popescu O, Iosif L et al (2016) Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats. Braz J Med Biol Res 49:e5116PubMedPubMedCentral
42.
Zurück zum Zitat Santos MA, Oliveira CV, Silva AS (2014) Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources. Subst Use Misuse 49:1132–1137CrossRefPubMed Santos MA, Oliveira CV, Silva AS (2014) Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources. Subst Use Misuse 49:1132–1137CrossRefPubMed
43.
Zurück zum Zitat Vanberg P, Atar D (2010) Androgenic anabolic steroid abuse and the cardiovascular system. Handb Exp Pharmacol 195:411–457CrossRef Vanberg P, Atar D (2010) Androgenic anabolic steroid abuse and the cardiovascular system. Handb Exp Pharmacol 195:411–457CrossRef
44.
Zurück zum Zitat Nieschlag E, Vorona E (2015) Doping with anabolic androgenic steroids (AAS): adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord 16:199–211CrossRefPubMed Nieschlag E, Vorona E (2015) Doping with anabolic androgenic steroids (AAS): adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord 16:199–211CrossRefPubMed
45.
Zurück zum Zitat Zmuda JM, Fahrenbach MC, Younkin BT, Bausseman LL, Terry RB, Catlin DH et al (1993) The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity. Metabolism 42:446–450CrossRefPubMed Zmuda JM, Fahrenbach MC, Younkin BT, Bausseman LL, Terry RB, Catlin DH et al (1993) The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity. Metabolism 42:446–450CrossRefPubMed
46.
Zurück zum Zitat Ebenbichler CF, Sturm W, Gänzer H, Bodner J, Manqweth B, Ritsch A et al (2001) Flow mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids. Atherosclerosis 158:483–490CrossRefPubMed Ebenbichler CF, Sturm W, Gänzer H, Bodner J, Manqweth B, Ritsch A et al (2001) Flow mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids. Atherosclerosis 158:483–490CrossRefPubMed
47.
Zurück zum Zitat Zheng XY, Liu L (2007) Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase. J Lipid Res 48(8):1673–1680CrossRefPubMed Zheng XY, Liu L (2007) Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase. J Lipid Res 48(8):1673–1680CrossRefPubMed
48.
Zurück zum Zitat Laterza MC, De Matos LD, Trombetta IC, Braga AM, Roveda F, Alves MJ et al (2007) Exercise training restores baroreflex sensitivity in never-treated hypertensive patients. Hypertension 49:1298–1306CrossRefPubMed Laterza MC, De Matos LD, Trombetta IC, Braga AM, Roveda F, Alves MJ et al (2007) Exercise training restores baroreflex sensitivity in never-treated hypertensive patients. Hypertension 49:1298–1306CrossRefPubMed
49.
Zurück zum Zitat Rahnemaye F, Nourani R, Spadari RC, De Moraes SF (1992) Stress-induced supersensitivity to isoprenaline in the isolated pacemaker of the rat: effects of the compounds RU-38486 and RU-28362. Gen Pharmacol 23:787–791CrossRefPubMed Rahnemaye F, Nourani R, Spadari RC, De Moraes SF (1992) Stress-induced supersensitivity to isoprenaline in the isolated pacemaker of the rat: effects of the compounds RU-38486 and RU-28362. Gen Pharmacol 23:787–791CrossRefPubMed
50.
Zurück zum Zitat Namakanov BA, Rasulov MM, Mitrokhina NE, Valeeva DR, Karaulova LK (2005) Myocardial hypertrophy of the left ventricle during familial arterial hypertension. Bull Exp Biol Med 40:675–676CrossRef Namakanov BA, Rasulov MM, Mitrokhina NE, Valeeva DR, Karaulova LK (2005) Myocardial hypertrophy of the left ventricle during familial arterial hypertension. Bull Exp Biol Med 40:675–676CrossRef
51.
Zurück zum Zitat Neves VJ, Tanno AP, Cunha TS, Fernandes T, Guzzoni V, Silva CA et al (2013) Effects of nandrolone and resistance training on the blood pressure, cardiac electrophysiology, and expression of atrial β-adrenergic receptors. Life Sci 92:1029–1035CrossRefPubMed Neves VJ, Tanno AP, Cunha TS, Fernandes T, Guzzoni V, Silva CA et al (2013) Effects of nandrolone and resistance training on the blood pressure, cardiac electrophysiology, and expression of atrial β-adrenergic receptors. Life Sci 92:1029–1035CrossRefPubMed
52.
Zurück zum Zitat Routledge HC, Chowdhary S, Townend JN (2002) Heart rate variability—a therapeutic target? J Clin Pharm Ther 27:85–92CrossRefPubMed Routledge HC, Chowdhary S, Townend JN (2002) Heart rate variability—a therapeutic target? J Clin Pharm Ther 27:85–92CrossRefPubMed
53.
Zurück zum Zitat Huikuri HV, Mäkikallio TH, Raatikainen MJP, Perkiömäki J, Castellanos A, Myerburg RJ (2003) Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 108:110–115CrossRefPubMed Huikuri HV, Mäkikallio TH, Raatikainen MJP, Perkiömäki J, Castellanos A, Myerburg RJ (2003) Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 108:110–115CrossRefPubMed
54.
Zurück zum Zitat Pruvot E, Thonet G, Vesin JM, van Melle G, Seidl K, Schmidinger H et al (2000) Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation 101:2398–2404CrossRefPubMed Pruvot E, Thonet G, Vesin JM, van Melle G, Seidl K, Schmidinger H et al (2000) Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation 101:2398–2404CrossRefPubMed
55.
Zurück zum Zitat Kollai M, Koizumi K (1979) Reciprocal and non-reciprocal action of the vagal and sympathetic nerves innervating the heart. J Auton Nerv Sys 1:33–52CrossRef Kollai M, Koizumi K (1979) Reciprocal and non-reciprocal action of the vagal and sympathetic nerves innervating the heart. J Auton Nerv Sys 1:33–52CrossRef
56.
Zurück zum Zitat Wessel N, Ziehmann C, Kurths J, Meyerfeldt U, Schirdewan A, Voss A (2000) Short-term forecasting of life-threatening cardiac arrhythmias based on symbolic dynamics and finite-time growth rates. Phys Rev E 61:733–739CrossRef Wessel N, Ziehmann C, Kurths J, Meyerfeldt U, Schirdewan A, Voss A (2000) Short-term forecasting of life-threatening cardiac arrhythmias based on symbolic dynamics and finite-time growth rates. Phys Rev E 61:733–739CrossRef
57.
Zurück zum Zitat Shusterman V, Aysin B, Gottipaty V, Weiss R, Brode S, Schwartzman D et al (1998) Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. J Am Coll Cardiol 32:1891–1899CrossRefPubMed Shusterman V, Aysin B, Gottipaty V, Weiss R, Brode S, Schwartzman D et al (1998) Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. J Am Coll Cardiol 32:1891–1899CrossRefPubMed
58.
Zurück zum Zitat Malliani A, Schwartz PJ, Zanchetti A (1980) Neural mechanisms in life-threatening arrhythmias. Am Heart J 100:705–715CrossRefPubMed Malliani A, Schwartz PJ, Zanchetti A (1980) Neural mechanisms in life-threatening arrhythmias. Am Heart J 100:705–715CrossRefPubMed
59.
Zurück zum Zitat Stolt A, Karila T, Viitasalo M, Mäntysaari M, Kujala UM, Karjalainen J (1999) QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids. Am J Cardiol 84:364–366CrossRefPubMed Stolt A, Karila T, Viitasalo M, Mäntysaari M, Kujala UM, Karjalainen J (1999) QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids. Am J Cardiol 84:364–366CrossRefPubMed
60.
Zurück zum Zitat Medei E, Marocolo M, Rodrigues DC, Arantes PC, Takiya CM, Silva J et al (2010) Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: cellular, ionic and molecular mechanism. J Mol Cell Cardiol 49:165–175CrossRefPubMed Medei E, Marocolo M, Rodrigues DC, Arantes PC, Takiya CM, Silva J et al (2010) Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: cellular, ionic and molecular mechanism. J Mol Cell Cardiol 49:165–175CrossRefPubMed
61.
Zurück zum Zitat Mayet J, Shahi M, McGrath K, Poulter NR, Sever PS, Foale RA et al (1996) Left ventricular hypertrophy and QT dispersion in hipertension. Hypertension 28:791–796CrossRefPubMed Mayet J, Shahi M, McGrath K, Poulter NR, Sever PS, Foale RA et al (1996) Left ventricular hypertrophy and QT dispersion in hipertension. Hypertension 28:791–796CrossRefPubMed
62.
Zurück zum Zitat Nieminen MS, Rämo MP, Viitasalo M, Heikkilä P, Karjalainen J, Mäntysaari M et al (1996) Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 17:1576–1583CrossRefPubMed Nieminen MS, Rämo MP, Viitasalo M, Heikkilä P, Karjalainen J, Mäntysaari M et al (1996) Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 17:1576–1583CrossRefPubMed
63.
Zurück zum Zitat D’Andrea A, Limongelli G, Caso P, Sarubbi B, Della Pietra A, Brancaccio P et al (2002) Association between left ventricular structure and cardiac performance during effort in two morphological forms of athlete’s heart. Int J Cardiol 86:177–184CrossRefPubMed D’Andrea A, Limongelli G, Caso P, Sarubbi B, Della Pietra A, Brancaccio P et al (2002) Association between left ventricular structure and cardiac performance during effort in two morphological forms of athlete’s heart. Int J Cardiol 86:177–184CrossRefPubMed
64.
Zurück zum Zitat Rahman F, Pechnik S, Gross D, Sewell L, Goldstein DS (2011) Low frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Clin Auton Res 21:133–141CrossRefPubMedPubMedCentral Rahman F, Pechnik S, Gross D, Sewell L, Goldstein DS (2011) Low frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Clin Auton Res 21:133–141CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Martelli D, Silvani A, McAllen RM, May CN, Ramchandra R (2014) The low frequency power of heart rate variability is neither a measure of cardiac sympathetic tone nor of baroreflex sensitivity. Am J Physiol Heart Circ Physiol 307:H1005–H1012CrossRefPubMed Martelli D, Silvani A, McAllen RM, May CN, Ramchandra R (2014) The low frequency power of heart rate variability is neither a measure of cardiac sympathetic tone nor of baroreflex sensitivity. Am J Physiol Heart Circ Physiol 307:H1005–H1012CrossRefPubMed
66.
Zurück zum Zitat Goldstein DS, Bentho O, Park MY, Sharabi Y (2011) Low frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol 96:1255–1261CrossRefPubMedPubMedCentral Goldstein DS, Bentho O, Park MY, Sharabi Y (2011) Low frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol 96:1255–1261CrossRefPubMedPubMedCentral
67.
Zurück zum Zitat Burggren WW, Monticino MG (2005) Assessing physiological complexity. J Exp Biol 208:3221–3232CrossRefPubMed Burggren WW, Monticino MG (2005) Assessing physiological complexity. J Exp Biol 208:3221–3232CrossRefPubMed
68.
Zurück zum Zitat Porta A, Baselli G, Liberati D, Montano N, Cogliati C, Gnecchi-Ruscone T et al (1998) Measuring regularity by means of a corrected conditional entropy in sympathetic outflow. Biol Cybern 78:71–78CrossRefPubMed Porta A, Baselli G, Liberati D, Montano N, Cogliati C, Gnecchi-Ruscone T et al (1998) Measuring regularity by means of a corrected conditional entropy in sympathetic outflow. Biol Cybern 78:71–78CrossRefPubMed
69.
Zurück zum Zitat Moura-Tonello SCG, Porta A, Marchi A, Almeida Fagundes A, Oliveira Francisco C, Rehder-Santos P et al (2016) Cardiovascular variability analysis and baroreflex estimation in patients with type 2 diabetes in absence of any manifest neuropathy. PLoS One 11:e0148903CrossRefPubMedPubMedCentral Moura-Tonello SCG, Porta A, Marchi A, Almeida Fagundes A, Oliveira Francisco C, Rehder-Santos P et al (2016) Cardiovascular variability analysis and baroreflex estimation in patients with type 2 diabetes in absence of any manifest neuropathy. PLoS One 11:e0148903CrossRefPubMedPubMedCentral
70.
Zurück zum Zitat Makikallio TH, Tapanainen JM, Tulppo MP, Huikuri HV (2002) Clinical applicability of heart rate variability analysis by methods based on nonlinear dynamics. Card Electrophysiol Rev 6:250–255CrossRefPubMed Makikallio TH, Tapanainen JM, Tulppo MP, Huikuri HV (2002) Clinical applicability of heart rate variability analysis by methods based on nonlinear dynamics. Card Electrophysiol Rev 6:250–255CrossRefPubMed
71.
Zurück zum Zitat Porta A, Faes L, Mase M, D’Addio G, Pinna GD, Maestri R et al (2007) An integrated approach based on uniform quantization for the evaluation of complexity of short-term heart period variability: application to 24 h Holter recordings in healthy and heart failure humans. Chaos 17:015117CrossRefPubMed Porta A, Faes L, Mase M, D’Addio G, Pinna GD, Maestri R et al (2007) An integrated approach based on uniform quantization for the evaluation of complexity of short-term heart period variability: application to 24 h Holter recordings in healthy and heart failure humans. Chaos 17:015117CrossRefPubMed
Metadaten
Titel
Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities
verfasst von
Octávio Barbosa Neto
Gustavo Ribeiro da Mota
Carla Cristina De Sordi
Elisabete Aparecida M. R. Resende
Luiz Antônio P. R. Resende
Marco Antônio Vieira da Silva
Moacir Marocolo
Rafael Silva Côrtes
Lucas Felipe de Oliveira
Valdo José Dias da Silva
Publikationsdatum
10.10.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Autonomic Research / Ausgabe 2/2018
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-017-0470-2

Weitere Artikel der Ausgabe 2/2018

Clinical Autonomic Research 2/2018 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie